291 related articles for article (PubMed ID: 29843108)
1. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
[TBL] [Abstract][Full Text] [Related]
3. Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.
Akman D; Denzinger K; Huang S; Lee JT; Nafie JW; Wolber G; Zamponi GW; Armstrong DW; Gündüz MG
Eur J Med Chem; 2022 Dec; 244():114787. PubMed ID: 36209630
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels.
Aygün Cevher H; Schaller D; Gandini MA; Kaplan O; Gambeta E; Zhang FX; Çelebier M; Tahir MN; Zamponi GW; Wolber G; Gündüz MG
Bioorg Chem; 2019 Oct; 91():103187. PubMed ID: 31419643
[TBL] [Abstract][Full Text] [Related]
6. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
Bladen C; Gadotti VM; Gündüz MG; Berger ND; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2015 Jun; 467(6):1237-47. PubMed ID: 24990197
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.
Kang S; Cooper G; Dunne SF; Luan CH; James Surmeier D; Silverman RB
Bioorg Med Chem; 2013 Jul; 21(14):4365-73. PubMed ID: 23688558
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
10. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
Drígelová M; Tarabová B; Duburs G; Lacinová L
Can J Physiol Pharmacol; 2009 Nov; 87(11):923-32. PubMed ID: 19935900
[TBL] [Abstract][Full Text] [Related]
11. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Jul; 88():102915. PubMed ID: 31005784
[TBL] [Abstract][Full Text] [Related]
13. A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes.
Galvis-Pareja D; Zapata-Torres G; Hidalgo J; Ayala P; Pedrozo Z; Ibarra C; Diaz-Araya G; Hall AR; Vicencio JM; Nuñez-Vergara L; Lavandero S
Toxicol Appl Pharmacol; 2014 Aug; 279(1):53-62. PubMed ID: 24844443
[TBL] [Abstract][Full Text] [Related]
14. Ca
Toyoda F; Mesirca P; Dubel S; Ding WG; Striessnig J; Mangoni ME; Matsuura H
Sci Rep; 2017 Aug; 7(1):7869. PubMed ID: 28801600
[TBL] [Abstract][Full Text] [Related]
15. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
Ogihara T; Kano T; Kakinuma C
Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
[TBL] [Abstract][Full Text] [Related]
18. Molecular simulations study of novel 1,4-dihydropyridines derivatives with a high selectivity for Cav3.1 calcium channel.
Liu X; Yu H; Zhao X; Huang XR
Protein Sci; 2015 Nov; 24(11):1737-47. PubMed ID: 26256672
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
Takahashi D; Oyunzul L; Onoue S; Ito Y; Uchida S; Simsek R; Gunduz MG; Safak C; Yamada S
Biol Pharm Bull; 2008 Mar; 31(3):473-9. PubMed ID: 18310913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
